Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

IL-12 p40 prevents the development of chronic enterocolitis in IL-10-deficient mice.

Shiraki M, Aihara H, Kinouchi Y, Takahashi S, Oki M, Noguchi M, Takahashi K, Miyazaki J, Shimosegawa T.

Lab Invest. 2004 Nov;84(11):1491-500.

2.

Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation.

Rennick DM, Fort MM.

Am J Physiol Gastrointest Liver Physiol. 2000 Jun;278(6):G829-33. Review.

3.

Chronic colitis in IL-10-/- mice: insufficient counter regulation of a Th1 response.

Davidson NJ, Fort MM, Müller W, Leach MW, Rennick DM.

Int Rev Immunol. 2000;19(1):91-121. Review.

PMID:
10723680
4.

IL-12: the role of p40 versus p75.

Abdi K.

Scand J Immunol. 2002 Jul;56(1):1-11. Review.

5.

Ustekinumab: lessons learned from targeting interleukin-12/23p40 in immune-mediated diseases.

Elliott M, Benson J, Blank M, Brodmerkel C, Baker D, Sharples KR, Szapary P.

Ann N Y Acad Sci. 2009 Dec;1182:97-110. doi: 10.1111/j.1749-6632.2009.05070.x. Review.

PMID:
20074279
6.

Anti-IL-12/23 in Crohn's disease: bench and bedside.

Niederreiter L, Adolph TE, Kaser A.

Curr Drug Targets. 2013 Nov;14(12):1379-84. Review.

PMID:
24138637
7.

Genetic and environmental context determines the course of colitis developing in IL-10-deficient mice.

Mähler M, Leiter EH.

Inflamm Bowel Dis. 2002 Sep;8(5):347-55. Review.

PMID:
12479650
8.

The IL-12 family member p40 chain as a master switch and novel therapeutic target in psoriasis.

Nestle FO, Conrad C.

J Invest Dermatol. 2004 Dec;123(6):xiv-xv. Review. No abstract available.

Supplemental Content

Support Center